Compare CPRI & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRI | NEOG |
|---|---|---|
| Founded | 1981 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.3B |
| IPO Year | 2011 | 1995 |
| Metric | CPRI | NEOG |
|---|---|---|
| Price | $19.21 | $9.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $26.50 | $10.67 |
| AVG Volume (30 Days) | ★ 2.7M | 2.7M |
| Earning Date | 05-04-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.18 | 0.09 |
| Revenue | ★ $4,442,000,000.00 | $894,661,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.86 | $1.67 |
| P/E Ratio | ★ $15.18 | $107.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.86 | $3.87 |
| 52 Week High | $28.27 | $11.43 |
| Indicator | CPRI | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 37.61 | 37.84 |
| Support Level | $16.62 | $8.93 |
| Resistance Level | $19.62 | $10.30 |
| Average True Range (ATR) | 0.94 | 0.42 |
| MACD | -0.08 | -0.26 |
| Stochastic Oscillator | 34.14 | 29.27 |
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.